Medpace Holdings share price logo

Medpace Holdings

NASDAQ: MEDP

Large Cap

$653.96

-8.52

(-1.29%)

as on

Medpace Holdings Stock Performance

as on October 23, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $645.74
    $684.00
    downward going graph

    1.26%

    Downside

    4.59%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $373.00
    $684.52
    downward going graph

    42.96%

    Downside

    4.67%

    Upside

    downward going graph

Medpace Holdings share price movements today

Previous Close
$662.48
Open
$659.38
Volume
706.3K
Market Cap
$18.5B
Day's Low - High
$645.74 - $684.00
52 Week Low - High
$373.00 - $684.52

Medpace Holdings Historical Returns

1 Month Return
+ 5.96 %
3 Month Return
+ 7.95 %
1 Year Return
+ 9.61 %
3 Year Return
+ 187.43 %
5 Year Return
+ 249.64 %

Medpace Holdings Stock Fundamentals & Key Indicators

Check Medpace Holdings market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$18.5B

EPS (TTM)

17.39

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.37%

PE Ratio (TTM)

36.08

Industry PE ratio

19.52

PEG Ratio

1.43

EBITDA

615.9M

Revenue (TTM)

2.8B

Profit Margin

29.14%

Return On Equity TTM

99.76%

Medpace Holdings vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Medpace Holdings with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Buy$18.5B249.64%36.0829.14%0.00%
StrongBuy$59.6B249.23%-303.9665.30%0.00%
StrongBuy$48.8B10.08%34.9253.73%0.57%
StrongBuy$254.2B10.55%36.5541.44%0.27%
StrongBuy$157.6B-26.69%38.2558.59%0.65%

Stock Returns calculator for Medpace Holdings Stock including INR - Dollar returns

The Medpace Holdings stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Medpace Holdings investment value today

Current value as on today

₹1,18,555

Returns

₹18,555

(+18.55%)

Returns from Medpace Holdings Stock

₹9,613 (+9.61%)

Dollar Impact

₹8,942 (+8.94%)

Analyst Recommendation on Medpace Holdings Stock

Based on 7 analysts

BUY

28.57%

Buy

71.43%

Hold

0.00%

Sell

Based on 7 analysts, 71.42857142857143% of analysts recommend a 'BUY' rating for Medpace Holdings. Average target price of $595.92

Medpace Holdings Share Price Target

Get share price movements and forecasts by analysts on Medpace Holdings.

What analysts predicted

-9.74%DOWNSIDE

Target Price

$595.92

Current Price

$653.96

Analyzed by

7 Analysts

High

$700

Target

$595.92

Low

$492

Medpace Holdings target price $595.92, a slight downside of -9.74% compared to current price of $653.96. According to 7 analysts rating.

Indian Investors' Interest in Medpace Holdings Stock

Search interest for Medpace Holdings Stock has increased by 54% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:54% versus previous 30 day period

Medpace Holdings Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
511
528
533
536
558
603
659
708
706
707
Gross Profit
155
153
169
178
178
180
196
205
196
201
Operating Income
104
105
112
125
113
126
141
153
141
146
EBITDA
119
117
126
141
125
131
149
163
154
147
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
6
7
7
7
6
7
7
7
6
6
Income Before Tax
112
110
118
133
118
124
142
156
147
151
Income Tax Expense
10
22
22
16
3
34
31
21
23
30
Net Income
102
88
96
117
114
90
111
135
123
121
Net Profit Margin
30.36%
29.13%
31.69%
33.23%
31.93%
29.84%
29.84%
28.98%
27.78%
28.51%

Medpace Holdings Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
436
704
860
925
1,142
1,459
1,885
2,109
2,530
Gross Profit
174
215
245
278
328
432
524
656
760
Operating Income
64
101
127
167
198
278
336
446
534
EBITDA
110
139
150
186
223
308
362
505
570
Interest Expense
7
8
1
-
0
2
0
-
-
Depreciation
46
38
23
19
21
22
26
29
28
Income Before Tax
56
93
124
168
201
282
335
475
542
Income Tax Expense
17
20
24
23
20
37
52
71
91
Net Income
39
73
100
145
181
245
282
404
451
Net Profit Margin
40.05%
30.59%
28.54%
30.10%
28.73%
29.62%
27.81%
31.12%
30.06%

Medpace Holdings Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
102
88
96
117
114
90
111
135
123
121
Operating Cash Flow
152
116
149
190
125
148
246
192
151
162
Investing Cash Flow
2
-12
-10
-7
-9
-6
-10
-4
-6
-23
Financing Cash Flow
7
0
6
-168
-345
-540
3
22
12
-288
Change in Cash
161
103
146
12
-228
-395
239
211
155
-149

Medpace Holdings Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
39
73
100
145
181
245
282
404
451
Operating Cash Flow
97
156
201
258
263
388
433
608
713
Investing Cash Flow
-12
-16
-19
-31
-31
-38
-34
-28
-31
Financing Cash Flow
-97
-141
-73
-82
-44
-775
-182
-154
-860
Change in Cash
-10
-3
108
145
183
-433
217
423
-172

Global Institutional Holdings in Medpace Holdings

Check out the Institutions with significant holdings in Medpace Holdings.

Funds
Holdings
iShares
8.95%
Vanguard
6.98%
VANGUARD INDEX FUNDS
6.39%
Capitol Series Trust
1.70%
SPDR
1.66%

Medpace Holdings News & Key Events

  • img

    Today's Timeline - 21 October

    Thu, 01:50 AM

    -

    Medpace reports Q3 EPS of $4.84, exceeding consensus of $4.46, with revenue also above expectations.

    Thu, 03:16 AM

    -

    Medpace announces $1 billion buyback program, signaling confidence in cash generation and capital flexibility.

Insights on Medpace Holdings

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, 121.36M → 137.45M (in $), with an average increase of 11.7% per quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 3 quarters, 706.60M → 716.00M (in $), with an average increase of 0.7% per quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 6 months, MEDP stock has moved up by 66.2%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Natera, Inc. Common Stock has given 901.4% return, outperforming this stock by 714.0%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Natera, Inc. Common Stock has given 105.8% return, outperforming this stock by 96.2%

About Medpace Holdings

Medpace Holdings, Inc., founded in Cincinnati, Ohio, in 1992, functions as a contract research organization (CRO) delivering clinical development and research services. The company assists pharmaceutical, biotechnology, and medical device clients throughout North America, Europe, and Asia. Its comprehensive suite of offerings covers the entire product lifecycle, from initial Phase I trials through to Phase IV post-market surveillance. Medpace's services include designing development programs, coordinating central laboratory functions, managing projects, navigating regulatory processes, overseeing clinical trials, handling data management and analytics, ensuring pharmacovigilance, aiding with new drug application submissions, and providing ongoing post-marketing clinical support. Furthermore, the company offers specialized bio-analytical laboratory testing, conducts clinical human pharmacology studies, provides imaging services, and delivers expert electrocardiography (ECG) reading for clinical research.
OrganisationMedpace Holdings
Headquarters5375 Medpace Way, Cincinnati, OH, 45227, US
IndustryMedical - Diagnostics & Research
CEOAugust James Troendle

Key Management of Medpace Holdings

Name

Title

Dr. August James Troendle M.D.

CEO, President & Chairman

Mr. Stephen P. Ewald J.D.

Chief Compliance Officer, General Counsel & Corporate Secretary

Mr. Brad W. Hansman

Executive Vice President of Operations

FAQs

What is Medpace Holdings share price today?

Medpace Holdings share price today is $653.96 as on at the close of the market. Medpace Holdings share today touched a day high of $684.00 and a low of $645.74.

What is the 52 week high and 52 week low for Medpace Holdings share?

Medpace Holdings share touched a 52 week high of $684.52 on and a 52 week low of $373.00 on . Medpace Holdings stock price today i.e. is closed at $653.96,which is 4.46% down from its 52 week high and 75.32% up from its 52 week low.

What is Medpace Holdings's market capitalisation today?

Medpace Holdings market capitalisation is $0.02T as on .

How to invest in Medpace Holdings Stock (MEDP) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Medpace Holdings on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Medpace Holdings Stock (MEDP) from India?

Indian investors can start investing in Medpace Holdings (MEDP) shares with as little as ₹94.94000244140625 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹949.40 in Medpace Holdings stock (as per the Rupee-Dollar exchange rate as on ). Based on Medpace Holdings share’s latest price of $653.96 as on October 23, 2026 at 8:46 am IST, you will get 0.0153 shares of Medpace Holdings. Learn more about fractional shares .

What are the returns that Medpace Holdings has given to Indian investors in the last 5 years?

Medpace Holdings stock has given 249.64% share price returns and 26.35% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?